Attached files
file | filename |
---|---|
10-Q/A - 10-Q/A - OMNI BIO PHARMACEUTICAL, INC. | c07684e10vqza.htm |
EX-31.2 - EXHIBIT 31.2 - OMNI BIO PHARMACEUTICAL, INC. | c07684exv31w2.htm |
EX-32.1 - EXHIBIT 32.1 - OMNI BIO PHARMACEUTICAL, INC. | c07684exv32w1.htm |
EX-31.1 - EXHIBIT 31.1 - OMNI BIO PHARMACEUTICAL, INC. | c07684exv31w1.htm |
Exhibit 32.2
CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
In connection with the Quarterly Report of Omni Bio Pharmaceutical, Inc. (the Company) on Form
10-Q/A for the quarter ended December 31, 2009 (the Report), I, Robert C. Ogden, Chief Financial
Officer of the Company, hereby certify that, to the best of my knowledge:
(1) | The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934 (15 U.S.C. 78m or 78o(d)); and | |
(2) | The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company for the period covered by this report. |
Date: November 8, 2010 | /s/ Robert C. Ogden | |||
Robert C. Ogden | ||||
Chief Financial Officer | ||||